Current Gene Therapy
Title:Editorial: Genetics and Gene Therapy of Lysosomial Storage Disorders
Volume: 18 Issue: 2
Author(s): Antonino Tuttolomondo
Affiliation:
Export Options
About this article
Cite this article as:
Tuttolomondo Antonino , Editorial: Genetics and Gene Therapy of Lysosomial Storage Disorders, Current Gene Therapy 2018; 18 (2) . https://dx.doi.org/10.2174/156652321802180507170539
DOI https://dx.doi.org/10.2174/156652321802180507170539 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Design, Preparation and Characterization of Modular Squalene-based Nanosystems for Controlled Drug Release
Current Topics in Medicinal Chemistry TNF-induced Lupus. A Case-Based Review
Current Rheumatology Reviews Editorial [ NeuroAIDS: A Neuroscience Problem with Global Impact ]
Current HIV Research Sphingolipids as Emerging Drug Targets: Therapeutic Applications of Ceramide Analogs
Drug Design Reviews - Online (Discontinued) Prostaglandins Pathway as a Possible Biological Link Between Cancer and Major Depression
Current Angiogenesis (Discontinued) The Endocannabinoid System and Multiple Sclerosis
Current Pharmaceutical Design Nanocrystalline ZnO: A Competent and Reusable Catalyst for the Preparation of Pharmacology Relevant Heterocycles in the Aqueous Medium
Current Green Chemistry Synthetic Peptides for the Immunodiagnosis of Human Diseases
Current Medicinal Chemistry Tau Silencing by siRNA in the P301S Mouse Model of Tauopathy
Current Gene Therapy Application of Nanotechnology in the Treatment and Diagnosis of Gastrointestinal Cancers: Review of Recent Patents
Recent Patents on Anti-Cancer Drug Discovery HIV-1 Proteins, Tat and gp120, Target the Developing Dopamine System
Current HIV Research HIV-Related Lymphoproliferative Diseases in the Era of Combination Antiretroviral Therapy
Cardiovascular & Hematological Disorders-Drug Targets NPY and Receptors in Immune and Inflammatory Diseases
Current Topics in Medicinal Chemistry Exploiting the Diversity of the Heat-Shock Protein Family for Primary and Secondary Tauopathy Therapeutics
Current Neuropharmacology Potential of Alphavirus Vectors in the Treatment of Advanced Solid Tumors
Recent Patents on Anti-Cancer Drug Discovery The Use of Metabolising Systems for In Vitro Testing of Endocrine Disruptors
Current Drug Metabolism Targeting RAS Signaling Pathways in Juvenile Myelomonocytic Leukemia
Current Drug Targets Immunoproteasome in Cancer and Neuropathologies: A New Therapeutic Target?
Current Pharmaceutical Design Dendrimer Based Anti-Infective and Anti-Inflammatory Drugs
Recent Patents on Anti-Infective Drug Discovery New Potential Serum Biomarkers in Multiple Sclerosis Identified by Proteomic Strategies
Current Medicinal Chemistry